Forwarded from Hank
#全球伊維菌素研究報告出爐
#大規模實證有效預防重症與死亡
伊維菌素是證實對治療Covid-19有效的藥物，特別是針對早期治療（死亡率降低81%）與預防（死亡率降低96%），諸如對於降低重症率與病毒量減低都有顯著的統計學意義，在多達60項學術研究報告中多達93%的報告顯示正面結果。
#Conclusion
Ivermectin is an effective treatment for COVID-19. The probability that an ineffective treatment generated results as positive as the 60 studies to date is estimated to be 1 in 2 trillion (p = 0.00000000000045). As expected for an effective treatment, early treatment is more successful, with an estimated reduction of 76% in the effect measured using random effects meta-analysis (RR 0.24 [0.14-0.41]). 81% and 96% lower mortality is observed for early treatment and prophylaxis (RR 0.19 [0.07-0.54] and 0.04 [0.00-0.58]). Statistically significant improvements are seen for mortality, ventilation, hospitalization, cases, and viral clearance. The consistency of positive results across a wide variety of heterogeneous studies is remarkable, with 93% of the 60 studies reporting positive effects (28 statistically significant in isolation).
報告內容非常詳細，歡迎醫學界人士積極參閱，並敦促CDC儘速推廣此藥用於早期治療與預防。
參閱報告：https://bit.ly/3iTxn7R
#請踴躍轉發讓更多醫界正義人士加入行列
https://m.facebook.com/story.php?story_fbid=350095749806842&id=100044192602059
#大規模實證有效預防重症與死亡
伊維菌素是證實對治療Covid-19有效的藥物，特別是針對早期治療（死亡率降低81%）與預防（死亡率降低96%），諸如對於降低重症率與病毒量減低都有顯著的統計學意義，在多達60項學術研究報告中多達93%的報告顯示正面結果。
#Conclusion
Ivermectin is an effective treatment for COVID-19. The probability that an ineffective treatment generated results as positive as the 60 studies to date is estimated to be 1 in 2 trillion (p = 0.00000000000045). As expected for an effective treatment, early treatment is more successful, with an estimated reduction of 76% in the effect measured using random effects meta-analysis (RR 0.24 [0.14-0.41]). 81% and 96% lower mortality is observed for early treatment and prophylaxis (RR 0.19 [0.07-0.54] and 0.04 [0.00-0.58]). Statistically significant improvements are seen for mortality, ventilation, hospitalization, cases, and viral clearance. The consistency of positive results across a wide variety of heterogeneous studies is remarkable, with 93% of the 60 studies reporting positive effects (28 statistically significant in isolation).
報告內容非常詳細，歡迎醫學界人士積極參閱，並敦促CDC儘速推廣此藥用於早期治療與預防。
參閱報告：https://bit.ly/3iTxn7R
#請踴躍轉發讓更多醫界正義人士加入行列
https://m.facebook.com/story.php?story_fbid=350095749806842&id=100044192602059
Ivmmeta
Ivermectin for COVID-19: real-time meta analysis of 60 studies
Ivermectin for COVID-19. Early treatment - 74% improvement, p < 0.0001. All studies - 69% improvement, p < 0.0001. 1 in 193 billion probability results of the 60 studies are from an ineffective treatment (p = 5.2e-12).
👍1